Document Detail


Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis.
MedLine Citation:
PMID:  23044767     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES:The gastrointestinal microbiota is considered important in inflammatory bowel disease (IBD) pathogenesis. Discoveries from established disease cohorts report reduced bacterial diversity, changes in bacterial composition, and a protective role for Faecalibacterium prausnitzii in Crohn's disease (CD). The majority of studies to date are however potentially confounded by the effect of treatment and a reliance on established rather than de-novo disease.METHODS:Microbial changes at diagnosis were examined by biopsying the colonic mucosa of 37 children: 25 with newly presenting, untreated IBD with active colitis (13 CD and 12 ulcerative colitis (UC)), and 12 pediatric controls with a macroscopically and microscopically normal colon. We utilized a dual-methodology approach with pyrosequencing (threshold >10,000 reads) and confirmatory real-time PCR (RT-PCR).RESULTS:Threshold pyrosequencing output was obtained on 34 subjects (11 CD, 11 UC, 12 controls). No significant changes were noted at phylum level among the Bacteroidetes, Firmicutes, or Proteobacteria. A significant reduction in bacterial α-diversity was noted in CD vs. controls by three methods (Shannon, Simpson, and phylogenetic diversity) but not in UC vs. controls. An increase in Faecalibacterium was observed in CD compared with controls by pyrosequencing (mean 16.7% vs. 9.1% of reads, P=0.02) and replicated by specific F. prausnitzii RT-PCR (36.0% vs. 19.0% of total bacteria, P=0.02). No disease-specific clustering was evident on principal components analysis.CONCLUSIONS:Our results offer a comprehensive examination of the IBD mucosal microbiota at diagnosis, unaffected by therapeutic confounders or changes over time. Our results challenge the current model of a protective role for F. prausnitzii in CD, suggesting a more dynamic role for this organism than previously described.Am J Gastroenterol advance online publication, 9 October 2012; doi:10.1038/ajg.2012.335.
Authors:
Richard Hansen; Richard K Russell; Caroline Reiff; Petra Louis; Freda McIntosh; Susan H Berry; Indrani Mukhopadhya; W Michael Bisset; Andy R Barclay; Jon Bishop; Diana M Flynn; Paraic McGrogan; Sabarinathan Loganathan; Gamal Mahdi; Harry J Flint; Emad M El-Omar; Georgina L Hold
Related Documents :
23946647 - Language impairment in alzheimer's disease and benefits of acetylcholinesterase inhibit...
25022367 - Sensitivity of spatiotemporal gait parameters in measuring disease severity in friedrei...
21551967 - A 6-year-old girl with hemoglobin h disease.
21514247 - Introduction to the recommendations from the national institute on aging-alzheimer's as...
10499307 - Clinical significance of apolipoprotein (a) deposition in kidney diseases of children.
11263477 - Hla dqa1*0501 and drb1*0301 antigens do not independently convey susceptibility to grav...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-09
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  -     ISSN:  1572-0241     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1] Gastrointestinal Research Group, Division of Applied Medicine, University of Aberdeen, Aberdeen, UK [2] Child Health, Royal Aberdeen Children's Hospital, University of Aberdeen, Aberdeen, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Paranasal sinus cholesterol granuloma: systematic review of diagnostic and management aspects.
Next Document:  Andrographis paniculata extract (HMPL-004) for active ulcerative colitis.